|
Website:
http://www.myriad.com
Phone: +1 801 584-3600 |
Address:
320 Wakara Way
Salt Lake City, UTAH 84108 |
Company Description
Myriad Genetics Inc. The Group's principal activity is to develop and market novel therapeutic and molecular diagnostic products. It operates in three segments: Research, Predictive Medicine and Drug Development. The Research segment focuses on the discovery of genes related to major common diseases. The Predictive Medicine segment provides testing to determine predisposition to common diseases. The Drug development segment is focused on the development of therapeutic products for the treatment and prevention of major diseases. The Group has made discoveries in the fields of cancer and AIDS. Predictive Medicine accounted for 88% of fiscal 2006 revenues and Research, 12%
Key People
| Chairman | Dr. John T. Henderson |
| President & Chief Executive | Peter D. Meldrum |
| Chief Financial Officer & Treasurer | Jay M. Moyes |
| Vice President Finance | James S. Evans |
| Executive Vice President, Secretary & General Counsel | Richard M. Marsh |
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
M
Myriad Genetic Laboratories, Inc.
Provider of commercial genetic predisposition testing services for breast and ovarian cancer, heart disease, stroke, hypertension and obesity. Services are provided to health care providers and counselors. This company was capitalized by priva...
www.myriad.com
Provider of commercial genetic predisposition testing services for breast and ovarian cancer, heart disease, stroke, hypertension and obesity. Services are provided to health care providers and counselors. This company was capitalized by priva...
www.myriad.com
Breaking News
Reuters - Nov. 23, 2009, 9:27 PM
Forbes.com - Nov. 20, 2009, 3:32 PM
Forbes.com - Nov. 18, 2009, 11:00 AM
CNBC - Nov. 16, 2009, 2:22 PM
CNBC - Nov. 4, 2009, 6:53 AM
More Myriad Genetics News
